z-logo
open-access-imgOpen Access
A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non–small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations
Author(s) -
Helena A. Yu,
Alexander I. Spira,
Leora Horn,
Jared Weiss,
Howard West,
Giuseppe Giaccone,
Tracey L. Evans,
Ronan J. Kelly,
Bina Desai,
Andrew Krivoshik,
Diarmuid M. Moran,
Srinivasu Poondru,
Jie Fei,
Kouji Aoyama,
Anne Keating,
Geoffrey R. Oxnard
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/m336-6m76
Subject(s) - epidermal growth factor receptor , lung , oncology , medicine , epidermal growth factor , cancer research , receptor , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here